Federation Des Caisses Desjardins Du Quebec Sanofi Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Sanofi stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 51,957 shares of SNY stock, worth $2.51 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

51,957

Previous 51,244 1.39%

Holding current value

$2.51 Million

Previous $2.49 Million 20.47%

% of portfolio

0.02%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$48.54 - $58.53 $34,609 - $41,731	713 Added 1.39%	51,957 $3 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $18,156 - $20,144	400 Added 0.79%	51,244 $2.49 Million
Q1 2024 May 15, 2024	BUY	$45.75 - $52.48 $2.33 Million - $2.67 Million	50,844 New	50,844 $2.47 Billion
Q4 2023 Aug 14, 2024	SELL	$43.13 - $54.79 $3.36 Million - $4.26 Million	-77,806 Reduced 59.61%	52,718 $2.62 Billion
Q3 2023 Aug 14, 2024	BUY	$50.95 - $55.2 $127,833 - $138,496	2,509 Added 1.96%	130,524 $7 Billion
Q2 2023 Aug 14, 2024	BUY	$50.45 - $57.18 $201,598 - $228,491	3,996 Added 3.22%	128,015 $6.9 Billion
Q1 2023 Aug 14, 2024	BUY	$45.86 - $54.45 $140,010 - $166,235	3,053 Added 2.52%	124,019 $6.75 Billion
Q4 2022 Aug 14, 2024	BUY	$38.86 - $48.55 $2.88 Million - $3.6 Million	74,078 Added 157.99%	120,966 $5.86 Billion
Q3 2022 Aug 14, 2024	BUY	$37.22 - $100.5 $22,034 - $59,496	592 Added 1.28%	46,888 $1.78 Billion
Q2 2022 Aug 14, 2024	SELL	$48.99 - $57.46 $35,860 - $42,060	-732 Reduced 1.56%	46,296 $2.32 Billion
Q1 2022 Aug 14, 2024	SELL	$48.48 - $53.65 $204,391 - $226,188	-4,216 Reduced 8.23%	47,028 $2.41 Billion
Q4 2021 Aug 30, 2024	BUY	$47.07 - $52.35 $72,346 - $80,461	1,537 Added 3.34%	47,489 $2.38 Billion
Q3 2021 Aug 30, 2024	BUY	$47.89 - $53.12 $48,847 - $54,182	1,020 Added 2.27%	45,952 $2.22 Billion
Q2 2021 Aug 30, 2024	SELL	$49.36 - $54.25 $311,560 - $342,426	-6,312 Reduced 12.32%	44,932 $2.37 Billion
Q1 2021 Aug 30, 2024	SELL	$45.46 - $50.51 $5.19 Million - $5.77 Million	-114,167 Reduced 72.61%	43,065 $2.13 Billion
Q4 2020 Aug 30, 2024	BUY	$45.3 - $51.62 $497,076 - $566,426	10,973 Added 7.5%	157,232 $7.64 Billion
Q3 2020 Aug 30, 2024	BUY	$49.47 - $53.77 $230,233 - $250,245	4,654 Added 3.29%	146,259 $7.34 Billion
Q2 2020 Aug 30, 2024	BUY	$42.91 - $52.5 $35,357 - $43,260	824 Added 0.59%	141,605 $7.23 Billion
Q1 2020 Aug 30, 2024	BUY	$38.02 - $51.66 $208,121 - $282,786	5,474 Added 4.05%	140,781 $6.15 Billion
Q4 2019 Aug 30, 2024	BUY	$44.25 - $50.86 $114,651 - $131,778	2,591 Added 1.95%	135,307 $6.79 Billion
Q3 2019 Aug 30, 2024	BUY	$40.34 - $46.64 $145,748 - $168,510	3,613 Added 2.8%	132,716 $6.15 Billion
Q2 2019 Aug 30, 2024	BUY	$40.43 - $44.3 $89,875 - $98,478	2,223 Added 1.75%	129,103 $5.59 Billion
Q1 2019 Aug 30, 2024	BUY	$40.83 - $45.43 $11,677 - $12,992	286 Added 0.23%	126,880 $5.62 Billion
Q4 2018 Aug 30, 2024	BUY	$41.48 - $45.59 $3.13 Million - $3.44 Million	75,350 Added 147.04%	126,594 $5.5 Billion
Q3 2018 Aug 30, 2024	BUY	$40.0 - $44.84 $114,560 - $128,421	2,864 Added 2.46%	119,112 $5.32 Billion
Q2 2018 Aug 30, 2024	BUY	$37.63 - $41.22 $3.51 Million - $3.84 Million	93,278 Added 406.09%	116,248 $4.65 Billion
Q1 2018 Aug 30, 2024	BUY	$38.98 - $45.76 $21,477 - $25,213	551 Added 2.46%	22,970 $921 Million
Q4 2017 Aug 30, 2024	BUY	$42.86 - $50.61 $1,628 - $1,923	38 Added 0.17%	22,419 $964 Million
Q3 2017 Aug 30, 2024	SELL	$47.04 - $50.34 $5,974 - $6,393	-127 Reduced 0.56%	22,381 $1.11 Billion
Q2 2017 Aug 30, 2024	SELL	N/A	-4,098 Reduced 15.4%	22,508 $1.08 Billion
Q1 2017 Aug 30, 2024	SELL	N/A	-24,638	26,606 $1.2 Billion

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Sanofi Transaction History